QUIT

Achieve Life Sciences, Inc. - Common Shares (QUIT)

About Achieve Life Sciences, Inc. - Common Shares (QUIT)

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.

Details

Daily high

$6.56

Daily low

$6.29

Price at open

$6.54

52 Week High

$8.64

52 Week Low

$2.62

Market cap

658.6M

Dividend yield

Volume

420,425

Avg. volume

1.3M

P/E ratio

-4.64

Achieve Life Sciences, Inc. - Common Shares News